-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – (Insulin Glargine + Insulin Lispro) LA in Type 2 Diabetes
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - (Insulin Glargine + Insulin Lispro) LA in Type 2 Diabetes report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. (Insulin Glargine + Insulin Lispro) LA...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Insulin Lispro U100 in Type 1 Diabetes (Juvenile Diabetes)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Insulin Lispro U100 in Type 1 Diabetes (Juvenile Diabetes) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Insulin Lispro U100 in Type 1 Diabetes...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – MesoCancerVac in Metastatic Pancreatic Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - MesoCancerVac in Metastatic Pancreatic Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. MesoCancerVac in Metastatic Pancreatic Cancer Drug Details: MesoCancerVac is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Binimetinib in Metastatic Colorectal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Binimetinib in Metastatic Colorectal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Binimetinib in Metastatic Colorectal Cancer Drug Details: Binimetinib (Mektovi) is...
-
Product Insights
Female Contraception – Drugs In Development, 2023
Global Markets Direct’s, ‘Female Contraception - Drugs In Development, 2023’, provides an overview of the Female Contraception pipeline landscape. The report provides comprehensive information on the therapeutics under development for Female Contraception, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – JNJ-8942 in Depression
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - JNJ-8942 in Depression report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.JNJ-8942 in Depression Drug Details:JNJ-8942 is under development for the treatment of depression and...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Insulin Lispro U200 in Type 1 Diabetes (Juvenile Diabetes)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Insulin Lispro U200 in Type 1 Diabetes (Juvenile Diabetes) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Insulin Lispro U200 in Type 1 Diabetes (Juvenile...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – (Insulin Glargine + Insulin Lispro) La in Type 2 Diabetes
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - (Insulin Glargine + Insulin Lispro) La in Type 2 Diabetes report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. (Insulin Glargine + Insulin Lispro) La...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Insulin Lispro U100 in Type 1 Diabetes (Juvenile Diabetes)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Insulin Lispro U100 in Type 1 Diabetes (Juvenile Diabetes) Drug Details:Insulin lispro is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Farudodstat in Alopecia Areata
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Farudodstat in Alopecia Areata report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Farudodstat in Alopecia AreataDrug Details:Farudodstat (ASLAN-003) is under development for the treatment of...